The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Regional differences observed in the phase 3 trial (ELM-PC 5) with orteronel (TAK-700) plus prednisone in patients with metastatic castration-resistant prostate cancer (mCRPC) that has progressed during or following docetaxel.
Karim Fizazi
Consultant or Advisory Role - Amgen; Astellas Pharma; Bayer; Bristol-Myers Squibb; Dendreon; Ipsen; Janssen; Medivation; Millennium; Novartis; Sanofi
Robert Jones
Honoraria - Astellas Pharma; Janssen; Sanofi
Research Funding - Astellas Pharma; AstraZeneca; Bristol-Myers Squibb; Janssen; Medivation; Millennium; Sanofi
Stephane Oudard
Consultant or Advisory Role - Janssen; Millennium; Novartis; Pfizer; Sanofi
Honoraria - Bristol-Myers Squibb; Millennium; Novartis; Pfizer; Sanofi
Research Funding - Bristol-Myers Squibb; Millennium; Novartis
Eleni Efstathiou
Consultant or Advisory Role - Bayer; Janssen; Medivation; Millennium; Sanofi
Honoraria - Janssen; Millennium; Sanofi
Research Funding - Janssen; Millennium; Sanofi ; Viamet Pharmaceuticals
Fred Saad
Consultant or Advisory Role - Astellas Pharma; Janssen; Millennium
Honoraria - Astellas Pharma; Janssen
Research Funding - Astellas Pharma; Janssen; Millennium
Ronald De Wit
Consultant or Advisory Role - Millennium
Honoraria - Millennium
Research Funding - Millennium
Johann Sebastian De Bono
Consultant or Advisory Role - Astellas Pharma; Johnson & Johnson; Medivation; Sanofi
Honoraria - Astellas Pharma; Johnson & Johnson; Medivation; Sanofi
Research Funding - AstraZeneca
Felipe Cruz
No relevant relationships to disclose
George Fountzilas
No relevant relationships to disclose
Albertas Ulys
No relevant relationships to disclose
Flavio Carcano
No relevant relationships to disclose
Neeraj Agarwal
Consultant or Advisory Role - Dendreon; Exelixis (U); Medivation (U)
David B. Agus
Consultant or Advisory Role - Millennium
Joaquim Bellmunt
Consultant or Advisory Role - Millennium
Daniel Peter Petrylak
Consultant or Advisory Role - Millennium
Research Funding - Millennium
Connie Lee
Employment or Leadership Position - Takeda
Bindu Tejura
Employment or Leadership Position - Takeda
Stock Ownership - Takeda
Niels Geert Borgstein
Employment or Leadership Position - Takeda
Stock Ownership - Takeda
Robert Dreicer
Consultant or Advisory Role - Dendreon; Endo Pharmaceuticals; Janssen; Medivation; Millennium
Honoraria - Dendreon; Janssen
Research Funding - BIND Biosciences; Endo Pharmaceuticals; Millennium; Progenics